One needs to differentiate shares in lieu of realistic cash salary vs performance rights and similar.
Free shares don't align directors interests with holders who have paid cold hard cash for theirs.
- Forums
- ASX - By Stock
- WR1
- WR1 Chart
WR1 Chart, page-319
-
-
- There are more pages in this discussion • 245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WR1 (ASX) to my watchlist
|
|||||
Last
68.0¢ |
Change
-0.050(6.85%) |
Mkt cap ! $147.1M |
Open | High | Low | Value | Volume |
73.0¢ | 73.0¢ | 68.0¢ | $388.7K | 552.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8049 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
70.0¢ | 12950 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8049 | 0.680 |
1 | 3430 | 0.675 |
3 | 19442 | 0.670 |
6 | 32196 | 0.665 |
5 | 84025 | 0.660 |
Price($) | Vol. | No. |
---|---|---|
0.700 | 12950 | 1 |
0.705 | 2442 | 1 |
0.710 | 4232 | 1 |
0.720 | 7800 | 1 |
0.725 | 645 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online